Audentes Therapeutics, Inc. Lease, Cost
Audentes Therapeutics, Inc. reported Lease, Cost of $1.50 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2019-11-07
- Audentes Therapeutics, Inc. lease, cost for the quarter ending 2019-09-30 was $1.50M.
- Audentes Therapeutics, Inc. lease, cost for the quarter ending 2019-06-30 was $2.00M.
- Audentes Therapeutics, Inc. lease, cost for the quarter ending 2019-03-31 was $1.40M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month |
|---|---|---|---|
| 2019-09-30 | $1.50M 10-Q · filed 2019-11-07 | $3.50M derived: sum of 2 quarters · filed 2019-11-07 | $4.40M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $2.00M 10-Q · filed 2019-08-07 | $3.40M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $1.40M 10-Q · filed 2019-05-08 |